Alpha-2 Receptor Agonists Market size is poised to reach USD 3.6 Billion by the end of 2036, growing at a CAGR of 8.7% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of alpha-2 receptor agonists was over USD 2.3 Billion.
This increase is due to the increased occurrence of hypertension and associated conditions. Approximately 1.28 billion persons worldwide, between the ages of 30 and 79, have hypertension, according to our study; low- and middle-income nations report the majority of instances.
Moreover, a number of metabolic illnesses have emerged globally due to the growing geriatric population and growing knowledge of behavioral and lifestyle changes. This has increased the need for specialized medications. Alpha-2 receptor agonists are becoming more and more popular as a therapeutic alternative because they can reduce blood pressure by inhibiting sympathetic activity in the brain.
Growth Drivers
Challenges
Base Year |
2023 |
Forecast Year |
2024-2036 |
CAGR |
8.7% |
Base Year Market Size (2023) |
USD 2.3 Billion |
Forecast Year Market Size (2036) |
USD 3.6 Billion |
Regional Scope |
|
Use (Hypertension, ADHD, Pain & Panic Disorder, ICU & Procedural Sedation)
In alpha-2 receptor agonists market, hypertension segment is poised to account for around 48% share by 2036. As a key risk factor for hypertension, this expansion is caused by an increase in the intake of unhealthy foods.
The number of persons who take medicine for hypertension or have a blood pressure of 140/90 mmHg or above is estimated to have doubled from 650 million to 1.3 billion between 1990 and 2020. Approximately 50% of hypertensive individuals globally are now ignorant of their illness. Alpha-2 receptor agonists are becoming more and more in demand as a result.
Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
The hospital pharmacies segment in alpha-2 receptor agonists market is anticipated to garner a major revenue share. The growth of the hospital pharmacies segment can be attributed to the fact that a significant number of people around the world with hypertension and related disorders tend to choose hospital facilities for treatment.
Additionally, hospital pharmacies have quickly become the preferred distribution channel for the customization of pharmaceutical ingredients to create medications tailored to individuals' needs. The presence of skilled professionals who can perform such tasks in hospitals has led to an increase in demand for drug-compounding procedures in hospital pharmacies, which has contributed to the segment's growth.
Our in-depth analysis of the global market includes the following segments:
Use |
|
Distribution Channel |
|
North American Market Forecast
By 2036, North America region is expected to account for around 45% alpha-2 receptor agonists market share. This growth can be impelled by the growing number of people suffering from attention-deficit/hyperactivity disorder (ADHD). In the United States, nearly 8.7 million adults in the United States are dealing with this disorder. Around 60% of children with ADHD in the US also have at least one other mental, emotional, or behavioral condition, such as depression or anxiety. In addition, an estimated 77% of children diagnosed with ADHD in the United States receive treatment.
APAC Market Statistics
The market in Asia Pacific is predicted to garner significant revenue share during forecast period. The incidence of hypertension-related disorders is on the rise and is a growing concern in the Asian region. The use of alpha-2 receptor agonists is becoming increasingly common, as the prevalence of hypertension in urban adult populations of Asia has been found to vary between 15-35%, as per new criteria (140/90 mm Hg).
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?